Retrieve Medical Holdings, Inc. RMHI
OTC · stock · Pharmaceutical Preparations · website · IPO 2010-05-17
Retrieve Medical Holdings, Inc. financials (annual, from 10-K)
Bars are annual figures from 2014 to 2022; red bars are negative (a loss or cash outflow).
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D expense | — | — | — | — | — | — | — | $13,051 | $30,000 | — |
| SG&A expense | — | — | — | — | — | $23,680 | $24,000 | — | — | — |
| Operating income | -$163,302 | -$68,721 | -$5,535 | -$5,684 | -$27,823 | -$44,987 | $1.1M | -$2.3M | — | -$956,876 |
| Interest expense | $32,081 | $10,397 | $9,476 | $8,309 | $5,584 | $1,240 | $0 | $2,202 | -$696,628 | $30,388 |
| Income tax | — | — | — | — | — | — | $0 | $0 | — | — |
| Net income | -$164,969 | -$76,089 | -$15,011 | -$13,993 | -$28,407 | -$51,227 | $1.2M | -$2.3M | -$3.8M | -$962,614 |
| Operating cash flow | -$68,553 | -$14,256 | -$119 | -$1,743 | -$43,721 | -$18,313 | -$200,352 | -$247,589 | -$933,475 | -$577,492 |
| Free cash flow | — | — | — | — | — | — | -$200,352 | -$249,775 | — | — |
| Cash & equivalents | — | — | $0 | $0 | $0 | $0 | — | — | $451,431 | $118,018 |
| Total assets | $130,349 | $261,152 | $408 | $527 | $2,270 | $2,991 | $1,304 | $281,370 | $490,908 | $146,888 |
| Total liabilities | $621,503 | $587,337 | $250,504 | $235,612 | $223,362 | $195,676 | $142,762 | $288,632 | $54,427 | $675,646 |
| Shareholders' equity | -$491,154 | -$326,185 | -$250,096 | -$235,085 | -$221,092 | -$192,685 | -$141,458 | -$7,262 | $436,481 | -$528,758 |
Growth · year-over-year
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income growth | — | — | — | — | — | -104.4% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001452804 · US · as of 2022-09-30. facts plus Stocktoria's own computed scores — not investment advice.